News | January 14, 2025
Odisha to implement AB PM-JAY scheme
The scheme is fully digitized and covers approximately 45% of India's population
The scheme is fully digitized and covers approximately 45% of India's population
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
TATA MD’s OmiSure is the only test approved by the ICMR for RT-PCR detection of the Omicron variant
The last-mile healthcare delivery across 1,100 villages, with focus on maternal health, diagnostics, and chronic disease management
Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network
The initiative, funded entirely under the company’s CSR programme, is expected to reach over a million lives
Nearly 1 in 3 HbA1c test results fall within the diabetic range, while 1 in 4 individuals show signs of prediabetes
Neuberg group commits to invest over Rs. 100 crores to start diagnostics facilities across Jharkhand in the next 2-3 years
Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs. 30 crores during FY 2024 and Rs. 7 crores in Q1 FY 2025
The campaign targets 63 endemic districts across Bihar, Jharkhand, Karnataka, Odisha, Telangana, and Uttar Pradesh
Subscribe To Our Newsletter & Stay Updated
